Merck (MRK), Institute for Systems Biology Collaborate to Define Molecular Mechanisms of SARS-CoV-2 Infection and Identify Potential Prognostic Biomarkers
Go back to Merck (MRK), Institute for Systems Biology Collaborate to Define Molecular Mechanisms of SARS-CoV-2 Infection and Identify Potential Prognostic Biomarkers| Merck & Co. (NYSE: MRK) | Delayed: 133.68 +3.26 (2.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.42 | 52 Week High | $65.46 | |||
| Open | $130.25 | 52 Week Low | $47.97 | |||
| Day High | $133.76 | P/E | 90.94 | |||
| Day Low | $128.91 | EPS | $1.47 | |||
| Volume | 6,933,677 | |||||

